Replies to post #30191 on Ocata Therapeutics Inc fka OCAT

[rocky301]

No time frames?
the first example shows it took almost 2 months from "positive opinion" announcement to actual approval..

the COMP adopted a positive opinion on 3 December 2009 recommending the granting of this designation.

On 2 February 2010, orphan designation (EU/3/09/720) was granted by the European Commission to Oxford BioMedica (UK) Ltd,
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=60795995

The other two were recent examples of companies that announced "positive opinions", as we did today, and have NOT received approval as of yet.

(49 days..no approval)
ZIOPHARM Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency
Jan 20, 2011
http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=544639

(44 days..no approval)
01/25/11 Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=irol-newsArticle_Print&ID=1519451&highlight=